These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 9215639)

  • 1. Recruitment of p300/CBP in p53-dependent signal pathways.
    Avantaggiati ML; Ogryzko V; Gardner K; Giordano A; Levine AS; Kelly K
    Cell; 1997 Jun; 89(7):1175-84. PubMed ID: 9215639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and modulation of p53 by p300/CBP coactivators.
    Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
    Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
    Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
    Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300.
    Miyagishi M; Fujii R; Hatta M; Yoshida E; Araya N; Nagafuchi A; Ishihara S; Nakajima T; Fukamizu A
    J Biol Chem; 2000 Nov; 275(45):35170-5. PubMed ID: 10906119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p300/CBP/p53 interaction and regulation of the p53 response.
    Grossman SR
    Eur J Biochem; 2001 May; 268(10):2773-8. PubMed ID: 11358491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for p300 in stabilization of p53 in the response to DNA damage.
    Yuan ZM; Huang Y; Ishiko T; Nakada S; Utsugisawa T; Shioya H; Utsugisawa Y; Yokoyama K; Weichselbaum R; Shi Y; Kufe D
    J Biol Chem; 1999 Jan; 274(4):1883-6. PubMed ID: 9890940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activation of transcription by CBP and p53.
    Gu W; Shi XL; Roeder RG
    Nature; 1997 Jun; 387(6635):819-23. PubMed ID: 9194564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.
    Zhang X; Grand RJ; McCabe CJ; Franklyn JA; Gallimore PH; Turnell AS
    Biochem J; 2002 Nov; 368(Pt 1):191-201. PubMed ID: 12164786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function for p300 and not CBP in the apoptotic response to DNA damage.
    Yuan ZM; Huang Y; Ishiko T; Nakada S; Utsugisawa T; Shioya H; Utsugisawa Y; Shi Y; Weichselbaum R; Kufe D
    Oncogene; 1999 Oct; 18(41):5714-7. PubMed ID: 10523850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
    Kawasaki H; Eckner R; Yao TP; Taira K; Chiu R; Livingston DM; Yokoyama KK
    Nature; 1998 May; 393(6682):284-9. PubMed ID: 9607768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the human involucrin gene promoter by co-activator proteins.
    Tran NQ; Crowe DL
    Biochem J; 2004 Jul; 381(Pt 1):267-73. PubMed ID: 15025563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
    Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-dependent acetylation of p53 by the transcription coactivator p300.
    Dornan D; Shimizu H; Perkins ND; Hupp TR
    J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.
    Meertens L; Pise-Masison C; Quere N; Brady J; Gessain A; Mahieux R
    Oncogene; 2004 Jul; 23(32):5447-58. PubMed ID: 15156194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.